Arcus Biosciences, Inc. (RCUS)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 15.55 |
| Open | 15.32 |
| Bid | 0.00 x 1000 |
| Ask | 0.00 x 800 |
| Day's range | 15.20 - 15.93 |
| 52-week range | 12.95 - 25.47 |
| Volume | |
| Avg. volume | 800,459 |
| Market cap | 1.422B |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Investors bid Arcus Biosciences (NYSE:RCUS) up US$219m despite increasing losses YoY, taking five-year CAGR to 8.1%
If you buy and hold a stock for many years, you'd hope to be making a profit. But more than that, you probably want to...
- GuruFocus.com
Insider Sell: COO Jennifer Jarrett Sells 11,551 Shares of Arcus Biosciences Inc (RCUS)
Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercialization of cancer immunotherapies, has reported an insider sell according to the latest SEC filings.
- GuruFocus.com
Insider Sell: COO Jennifer Jarrett Sells 13,449 Shares of Arcus Biosciences Inc (RCUS)
Arcus Biosciences Inc (NYSE:RCUS), a company focused on the discovery, development, and commercialization of cancer immunotherapies, has reported an insider sell according to a recent SEC filing.
© 2024 Yahoo. All rights reserved.